NSEChange in Management24 Jul 2026 · 24 Jul 2026, 07:51 pm
Change in Management
Onesource Specialty Pharma Limited · ONESOURCE
✦ AI SummaryMgmt Change
Onesource Specialty Pharma Limited has informed the Exchange about change in Management of the Company, with Preeti Kalra being designated as a Senior Management Personnel and Ravi Kumar resigning from his position.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Onesource Specialty Pharma Limited has informed the Exchange about change in Management of the Company
Attachments (1)
📄pdf
Download →
ONESOURCECDMO_24072026195108_SMP_Changes_intimationsigned.pdf
View document text
Corporate Office: Registered Office:
Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A,
Bannergha(cid:425)a Road, Bengaluru – 560076, Plot No - 4 & 6, Vashi,
India Navi Mumbai - 400703, India
T: +91 80 6784 0738 T: +91 22 2789 2924
F: +91 22 2789 2942
Date: July 24, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G,
Dalal Street Bandra Kurla Complex,
Mumbai- 400001 Bandra (E) Mumbai – 400051
Scrip Code: 544292 Symbol: ONESOURCE
Dear Sir/ Madam,
Subject: Changes in Senior Management Personnel (SMP) of the Company – Disclosure under Regulation 30 of
SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015
Pursuant to the requirements of Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform changes in the Senior Management
Personnel (“SMP”) of the Company, as under
Designated as SMP:
Preeti Kalra (Head - Human Resources) has been designated as a SMP of the Company effective July 24. 2026.
Cessation as SMP:
Ravi Kumar (Global Head – Injectables/ Head of Corporate Strategy, Portfolio & SPO), Senior Management Personnel
(SMP) of the Company has resigned from his position effective July 24, 2026.
Disclosure pursuant to Regulation 30 of the Listing Regulations, read with SEBI Master Circular No. HO/49/14/14(7)
2025-CFD-POD2/I/ 3762/2026, last updated on January 30, 2026, is enclosed herewith as Annexure 1 and Annexure 2
respectively.
This is for your information and records.
For and on behalf of
OneSource Specialty Pharma Limited
Trisha A
Company Secretary and Compliance Officer
Membership Number: A47635
OneSource Specialty Pharma Limited
Formerly Stelis Biopharma Limited
info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497
Corporate Office: Registered Office:
Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A,
Bannergha(cid:425)a Road, Bengaluru – 560076, Plot No - 4 & 6, Vashi,
India Navi Mumbai - 400703, India
T: +91 80 6784 0738 T: +91 22 2789 2924
F: +91 22 2789 2942
Annexure – 1
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, read with Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026
Designation of Preeti Kalra as SMP
Sl. Particulars Description
1. Reason for change viz. appointment, re- Designated as Senior Management Personnel
appointment, resignation, removal, death or
otherwise.
2. Date of cessation NA
3. Brief profile in case of appointment HR leader with 25+ years of experience across
Biopharma, Global Development (Not-for-Profit),
Public Services, Insurance, GCC and IT
Extensive leadership experience with organizations
including Stelis Biopharma, Biocon Biologics, Bill
& Melinda Gates Foundation, Serco and Ernst &
Young
Expertise in business partnering, talent
management, leadership development,
organizational transformation, culture, organization
effectiveness and change management
Proven track record of enabling business growth by
building high-performing teams, strengthening
leadership capability and driving organizational
effectiveness across Asia-Pacific, Middle East,
Africa, Europe and North America
4. Disclosure of relationship between directors Not Applicable
(in case of appointment of director)
OneSource Specialty Pharma Limited
Formerly Stelis Biopharma Limited
info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497
Corporate Office: Registered Office:
Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A,
Bannergha(cid:425)a Road, Bengaluru – 560076, Plot No - 4 & 6, Vashi,
India Navi Mumbai - 400703, India
T: +91 80 6784 0738 T: +91 22 2789 2924
F: +91 22 2789 2942
Annexure – 2
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, read with Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026
Cessation as SMP –Ravi Kumar
Sl. Particulars Description
1. Reason for change viz. appointment, re- Ceased to be a Senior Management Personnel consequent to
appointment, resignation, removal, death or resignation
otherwise.
2. Date of cessation NA
3. Brief profile in case of appointment Not applicable
4. Disclosure of relationship between directors Not Applicable
(in case of appointment of director)
OneSource Specialty Pharma Limited
Formerly Stelis Biopharma Limited
info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497